|
|
|
|
|
|
|
|
|
|
Previous: RIGEL PHARMACEUTICALS INC, S-1, EX-10.12, 2000-09-15 |
Next: RIGEL PHARMACEUTICALS INC, S-1, EX-27.1, 2000-09-15 |
<PAGE>
EXHIBIT 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the reference to our firm under the captions "Selected Financial
Data" and "Experts" and to the use of our report dated February 25, 2000, in the
Registration Statement (Form S-1) and related Prospectus of Rigel
Pharmaceuticals, Inc. for the registration of 10,350,000 shares of its common
stock.
/s/ ERNST & YOUNG LLP
Palo Alto, California
September 15, 2000
|
|